Invex Therapeutics Ltd (IXC.AX)
AUD 0.07
(0.0%)
AUD 0.07
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -1.64 Million AUD | 78.81% |
| 2023 | -7.74 Million AUD | -96.04% |
| 2022 | -3.95 Million AUD | -73.09% |
| 2021 | -2.28 Million AUD | 32.03% |
| 2020 | -3.36 Million AUD | -1347.63% |
| 2019 | -232.12 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -1.64 Million AUD | 78.81% |
| 2024 Q2 | -2.11 Million AUD | 0.0% |
| 2024 Q4 | 470.89 Thousand AUD | 0.0% |
| 2023 Q3 | -1.95 Million AUD | 49.3% |
| 2023 FY | -7.74 Million AUD | -96.04% |
| 2023 Q4 | -3.9 Million AUD | -100.0% |
| 2023 Q2 | -3.84 Million AUD | -100.0% |
| 2023 Q1 | -1.92 Million AUD | 10.81% |
| 2022 Q2 | -1.79 Million AUD | -100.0% |
| 2022 Q1 | -897.93 Thousand AUD | 26.87% |
| 2022 FY | -3.95 Million AUD | -73.09% |
| 2022 Q4 | -2.15 Million AUD | -100.0% |
| 2022 Q3 | -1.07 Million AUD | 39.94% |
| 2021 FY | -2.28 Million AUD | 32.03% |
| 2021 Q1 | -840.06 Thousand AUD | 62.66% |
| 2021 Q4 | -1.22 Million AUD | -100.0% |
| 2021 Q3 | -613.93 Thousand AUD | 41.87% |
| 2021 Q2 | -1.05 Million AUD | -25.71% |
| 2020 FY | -3.36 Million AUD | -1347.63% |
| 2020 Q4 | -2.24 Million AUD | -167.79% |
| 2020 Q3 | -840.06 Thousand AUD | 24.36% |
| 2020 Q2 | -1.11 Million AUD | -100.0% |
| 2020 Q1 | -555.31 Thousand AUD | 0.0% |
| 2019 Q3 | -11.19 Thousand AUD | 0.0% |
| 2019 FY | -232.12 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | 69.49% |
| Acrux Limited | -5.8 Million AUD | 71.693% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 88.163% |
| BTC Health Limited | 1.05 Million AUD | 255.579% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 86.897% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 96.121% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 104.607% |
| Biome Australia Limited | -1.67 Million AUD | 1.7% |
| Hexima Limited | -933.87 Thousand AUD | -75.806% |
| Immutep Limited | -39.89 Million AUD | 95.885% |
| Memphasys Limited | -4.44 Million AUD | 63.039% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 101.045% |
| Noxopharm Limited | -3.57 Million AUD | 54.115% |
| Prescient Therapeutics Limited | -8.23 Million AUD | 80.07% |
| Race Oncology Limited | -13.81 Million AUD | 88.119% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 96.576% |
| Starpharma Holdings Limited | -8.16 Million AUD | 79.892% |
| Tissue Repair Ltd | -4.13 Million AUD | 60.325% |
| Biotron Limited | -3.43 Million AUD | 52.225% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 91.415% |
| CSL Limited | 2.64 Billion AUD | 100.062% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 123.574% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -13.131% |
| Bio-Gene Technology Limited | -2.4 Million AUD | 31.852% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 95.51% |
| Patrys Limited | -3.53 Million AUD | 53.61% |
| Orthocell Limited | -7.18 Million AUD | 77.137% |
| Imugene Limited | -149.68 Million AUD | 98.903% |
| PYC Therapeutics Limited | -37.72 Million AUD | 95.648% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | 74.251% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 83.152% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 81.228% |
| Nanollose Limited | -1.15 Million AUD | -41.957% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 606.403% |
| Amplia Therapeutics Limited | -4.5 Million AUD | 63.543% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | 42.681% |
| Nyrada Inc. | -1.38 Million AUD | -18.437% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 131.507% |
| Dimerix Limited | -17.07 Million AUD | 90.385% |
| PharmAust Limited | -9.03 Million AUD | 81.823% |
| AnteoTech Limited | -8.88 Million AUD | 81.512% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 97.201% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 90.704% |
| Avecho Biotechnology Limited | -3.43 Million AUD | 52.225% |
| Actinogen Medical Limited | -13.04 Million AUD | 87.414% |
| Immuron Limited | -6.93 Million AUD | 76.332% |
| Argenica Therapeutics Limited | -5.47 Million AUD | 70.037% |